A Pfizer Inc. discovery in Groton has had ripple effects in Ireland.
Pfizer announced this week that it is expanding two manufacturing plants in Ireland, putting $100 million into its Grange Castle facility in Dublin to expand production of rheumatoid arthritis drug Xeljanz. The new remedy was developed in Groton.
Another $30 million will be invested at Pfizer's Ringaskiddy production facility in Cork that will allow for the expanded manufacture of new cancer drugs and other medicines on the way.
The announcement came only a month after Pfizer announced 177 job cuts related to a decline in off-patent sales, according to PharmaTimes.